Agenus Inc. (AGEN) by event type
AGEN moves most on analyst downgrades — a median of -4.29% at 30 minutes across 15 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AGEN overview →
How AGEN reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 435 of 2,717 | 12 | +0.42% | 58% | +3.75% |
| Analyst downgrades 2,579 of 2,603 | 15 | -4.29% | 13% | -4.96% |
| Rating reiterations 3,473 of 3,522 | 45 | -1.18% | 33% | -1.92% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how AGEN usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · AGEN overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Paratek Pharmaceuticals, Inc. (PRTK) | 891 | -0.18% | 44% |
| TRANSENTERIX (TRXC) | 884 | -0.71% | 39% |
| OncoSec Medical Incorporated (ONCS) | 878 | -0.49% | 39% |
| Genocea Biosciences, Inc. (GNCA) | 873 | -0.47% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.